Literature DB >> 18177929

The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization.

Jeong-Yeol Park1, Kyung Hee Lee, Seung Myung Dong, Sokbom Kang, Sang-Yoon Park, Sang-Soo Seo.   

Abstract

OBJECTIVE: The aim of this study was to evaluate whether the pre-conization high-risk human papilloma virus (HR-HPV) load is predictive for the persistence of HR-HPV infection and the persistence/recurrence of cervical intraepithelial neoplasia (CIN) after conization of the cervix.
MATERIALS AND METHODS: A retrospective review was performed on 236 women who underwent conization due to CIN at the Center for Uterine Cancer, National Cancer Center, Korea, between March 2001 and March 2006. The samples for pre-conization HR-HPV test were obtained at least within 3 weeks before conization. All patients underwent HR-HPV testing and cytology between 3 and 6 months after conization, and subsequent follow-up of 3- to 6-month interval was performed thereafter. The persistence of HR-HPV infection and persistence/recurrence of histologic abnormality after conization were analyzed by age, parity, menopausal status, method of conization, glandular extension, margin status, severity of CIN, and pre-cone HR-HPV load in univariate and multivariate analysis.
RESULTS: In univariate analysis, high pre-cone HR-HPV load was the only risk factor for the persistence of HR-HPV infection after conization (persistent HR-HPV infection; 19.8% [23/116] of patients with an HR-HPV load > or = 100 RLU/PC vs. 10.0% [12/120] of patients with a load < 100 RLU/PC, P=0.034). Multivariate analysis showed that an HR-HPV load > or = 100 RLU/PC was a risk factor for persistence/recurrence of histological abnormalities after conization (P=0.040, OR=5.748, 95% CI=1.082-30.526).
CONCLUSION: Patients with a pre-conization HR-HPV load > or = 100 RLU/PC had a higher rate of persistent HR-HPV infection and a higher rate of persistent/recurrent histological abnormalities after conization for CIN compared to patients with a load < 100 RLU/PC.

Entities:  

Mesh:

Year:  2008        PMID: 18177929     DOI: 10.1016/j.ygyno.2007.11.009

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  19 in total

1.  Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.

Authors:  Long Fu Xi; Mark Schiffman; James P Hughes; Denise A Galloway; Laura A Koutsky; Nancy B Kiviat
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-17       Impact factor: 4.254

2.  Role of high risk-human papilloma virus test in the follow-up of patients who underwent conization of the cervix for cervical intraepithelial neoplasia.

Authors:  Jeong-Yeol Park; Jaeman Bae; Myong Cheol Lim; So Yi Lim; Dong-Ock Lee; Sokbom Kang; Sang-Yoon Park; Byung-Ho Nam; Sang-Soo Seo
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

3.  Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases.

Authors:  Yusuke Tanaka; Yutaka Ueda; Mamoru Kakuda; Satoshi Kubota; Satoko Matsuzaki; Tadashi Iwamiya; Akiko Okazawa; Shinya Matsuzaki; Kae Hashimoto; Eiji Kobayashi; Seiji Mabuchi; Kenjiro Sawada; Takuji Tomimatsu; Kiyoshi Yoshino; Tadashi Kimura
Journal:  Int J Clin Oncol       Date:  2017-04-27       Impact factor: 3.402

Review 4.  Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.

Authors:  Sarah R Hoffman; Tam Le; Alexandre Lockhart; Ayodeji Sanusi; Leila Dal Santo; Meagan Davis; Dana A McKinney; Meagan Brown; Charles Poole; Corinne Willame; Jennifer S Smith
Journal:  Int J Cancer       Date:  2017-02-27       Impact factor: 7.396

5.  Factors associated with HPV persistence after conization in patients with negative margins.

Authors:  Kyehyun Nam; Sooho Chung; Jeongsig Kim; Seob Jeon; Donghan Bae
Journal:  J Gynecol Oncol       Date:  2009-06-29       Impact factor: 4.401

6.  Human Papillomavirus (HPV) type 16 and type 18 DNA Loads at Baseline and Persistence of Type-Specific Infection during a 2-year follow-up.

Authors:  Long Fu Xi; James P Hughes; Zoe R Edelstein; Nancy B Kiviat; Laura A Koutsky; Constance Mao; Jesse Ho; Mark Schiffman
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

7.  Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma?

Authors:  Yong Mi Kim; Jin Young Park; Kyung Mi Lee; Tae-Wook Kong; Seung-Chul Yoo; Woo Young Kim; Jong-Hyuck Yoon; Suk-Joon Chang; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

8.  Male circumcision reduces penile high-risk human papillomavirus viral load in a randomised clinical trial in Rakai, Uganda.

Authors:  Lauren E Wilson; Patti Gravitt; Aaron A R Tobian; Godfrey Kigozi; David Serwadda; Fred Nalugoda; Stephen Watya; Maria J Wawer; Ronald H Gray
Journal:  Sex Transm Infect       Date:  2012-10-30       Impact factor: 3.519

9.  Nomograms based on HPV load for predicting survival in cervical squamous cell carcinoma: An observational study with a long-term follow-up.

Authors:  Jing Zuo; Ying Huang; Jusheng An; Xi Yang; Ning Li; Manni Huang; Lingying Wu
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

10.  Early human papillomavirus testing predicts residual/recurrent disease after LEEP.

Authors:  Aeli Ryu; Kyehyun Nam; Jeongja Kwak; Jeongsig Kim; Seob Jeon
Journal:  J Gynecol Oncol       Date:  2012-09-19       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.